EGFR gene copy number in adenocarcinoma of the lung by FISH analysis: Investigation of significantly related factors on CT, FDG-PET, and histopathology
Authors:
- Hyun Ju LeeHLHyun Ju Lee
- Young Tae KimYKYoung Tae Kim
- Chang Hyun KangCKChang Hyun Kang
- Keon Wook KangKeon Wook Kang
- Yoon Kyung JeonYJYoon Kyung Jeon
- Jin Mo GooJGJin Mo Goo
- Chang Hyun LeeCLChang Hyun Lee
- Chang Min ParkCPChang Min Park
- 1 May 2009
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 64 (2) , 179-186
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Integrated PET/CT of Pulmonary Neuroendocrine Tumors: Diagnostic and Prognostic ImplicationsAmerican Journal of Roentgenology, 2007
- Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2006
- A Correlation between EGFR Gene Mutation Status and Bronchioloalveolar Carcinoma Features in Japanese Patients with AdenocarcinomaJapanese Journal of Clinical Oncology, 2006
- EGFR and erbB2 mutation status in Japanese lung cancer patientsInternational Journal of Cancer, 2005
- Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lungJournal of Clinical Pathology, 2005
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004